Search the Newsreel

Fuller & Thaler (GEF) reports 4.94% beneficial stake in Greif common stock

Fuller & Thaler Asset Management, Inc. has reported a 4.94% beneficial ownership stake in Greif, Inc. common stock, totaling 1,223,712.06 shares as of June 30, 2026. The filing, a Schedule 13G/A Amendment No. 5, indicates that Fuller & Thaler holds sole voting power over …

Sun Life Announces Conversion Privilege of Class A Non-Cumulative Rate Reset Preferred Shares Series 10R and Class A Non-Cumulative Floating Rate Preferred Shares Series 11QR

Sun Life Financial Inc. announced it will not redeem its Series 10R and Series 11QR preferred shares on September 30, 2026. As a result, shareholders have the option to convert their shares between these two series on a one-for-one basis, subject to minimum outstanding …

Valiant Capital discloses 5.3% Core Scientific (CORZ) position in amended 13G

Valiant Capital, along with its entities and Christopher R. Hansen, has disclosed a 5.3% beneficial ownership stake in Core Scientific (CORZ) through an amended Schedule 13G filing. This represents 16,956,009 shares of common stock, based on 321,340,441 shares outstanding as of July 23, 2026. …

Edwards Lifesciences Corp. stock underperforms Friday when compared to competitors

Edwards Lifesciences Corp. (EW) stock fell 1.04% on Friday, closing at $91.60. This underperformance occurred on a generally negative trading day for the stock market, with both the S&P 500 Index and the Dow Jones Industrial Average also declining. The stock experienced its third …

Riskified (RSKD) CSO Assaf Feldman sells 656,096 shares in planned trades

Riskified's Chief Strategy Officer – Tech, Assaf Feldman, has sold a total of 656,096 Class A Ordinary Shares in planned trades under a Rule 10b5-1 trading plan. These sales occurred on August 12, 2026, and August 14, 2026, for approximately $4.05 million. Feldman also …

Riskified (RSKD) CFO Dotcheva sells 260,000 shares in Rule 10b5-1 plan trades

Riskified Ltd.'s Chief Financial Officer, Aglika Dotcheva, sold a total of 260,000 Class A Ordinary Shares in two open-market transactions on August 12 and August 14, 2026. These sales were conducted under a pre-established Rule 10b5-1 trading plan adopted on September 15, 2025. The …

LFS Stock Surges As Leifras ADRs Lead Asian Gainers

LEIFRAS Co. Ltd. (LFS) stock surged 7.41% recently, with its ADRs jumping 11% in US trading, making it a top North Asian gainer. This significant movement, characterized by expanding intraday ranges, has attracted momentum traders. Despite its small-cap feel and volatility, LFS shows solid …

DoubleVerify (DV): Disciplined Growth Investors discloses 9.7M-share, 6.3% ownership stake

Disciplined Growth Investors, Inc. has disclosed a 6.3% ownership stake in DoubleVerify Holdings, Inc., beneficially owning 9,689,140 shares. The filing indicates the firm has sole voting power over 9,139,762 shares and sole dispositive power over all 9,689,140 shares, with no shared control. This Schedule …

OceanLink Partners Fund (ATAT) discloses 4.72% holding in Atour Lifestyle

OceanLink Partners Fund, LP has disclosed a 4.72% beneficial ownership in Atour Lifestyle Holdings Ltd, consisting of 15,780,456 Class A ordinary shares, represented by 5,260,152 American Depositary Shares (ADSs). This filing, a Schedule 13G/A amendment, indicates OceanLink holds sole voting and dispositive power over …

Suja Life (SUJA): Vive Aggregator entities report over 3.9M shares under joint control

QP Vive Aggregator, LLC and Non-QP Vive Aggregator, LLC, collectively known as Vive Aggregator entities, have reported beneficial ownership of over 3.9 million shares of Suja Life (SUJA) Class A common stock through a Schedule 13G filing. QP Vive Aggregator holds 5.7% (2,199,173 shares) …

Equifax Inc. stock underperforms Friday when compared to competitors

Equifax Inc. (EFX) saw its stock fall by 2.55% on Friday, closing at $180.85, a day when the broader market also experienced declines with the S&P 500 Index and Dow Jones Industrial Average dropping. This performance left Equifax Inc. 33.47% below its 52-week high …

RPG Life Sciences accepts Deepak Shukla's resignation as API head

Medifast (MED): Citadel entities and Kenneth Griffin disclose sub‑5% ownership stake

Citadel entities, including Citadel Securities LLC and Citadel Advisors LLC, along with Kenneth Griffin, have filed an amended Schedule 13G disclosing beneficial ownership of Medifast (MED) common stock. The filing indicates that each reporting person holds less than 5% of Medifast's outstanding shares, with …

RPG Life Sciences completes API business transfer to subsidiary

Core Scientific (CORZ): Jericho Capital and Josh Resnick disclose 7.2% ownership stake

Jericho Capital Asset Management L.P. and Josh Resnick have reported a joint beneficial ownership of 22,882,942 shares of Core Scientific, Inc. common stock, which represents 7.2% of the class. They share both voting and dispositive power over these shares. This disclosure was made via …

Pentwater Capital (NASDAQ: CORZ) discloses 1.34M-share Core Scientific position

Pentwater Capital Management LP and Matthew Halbower have disclosed a beneficial ownership of 1,336,594 shares of Core Scientific, Inc. common stock, representing 0.4% of the company's outstanding shares. This includes 800,000 shares issuable upon the exercise of options. All voting and dispositive authority over …

Cardiff Oncology (CRDF) asks investors to double authorized common shares

Cardiff Oncology (CRDF) is seeking stockholder approval to significantly increase its authorized capital stock, specifically doubling its common stock from 150 million to 300 million shares. This move aims to provide the company with greater flexibility for future financings, strategic transactions, equity incentives, and …

Achieve Life Sciences (ACHV) launches $150M at-the-market stock program

Achieve Life Sciences (ACHV) has established a $150 million at-the-market (ATM) equity offering program with Jefferies LLC as the sales agent. The company plans to sell common stock periodically, with net proceeds intended for the commercialization of cytisinicline, funding a Phase 3 clinical trial …

Union Pacific Corp. stock underperforms Friday when compared to competitors

Union Pacific Corp. (UNP) stock fell 1.38% on Friday, closing at $293.68, while the broader stock market experienced a grim trading session with the S&P 500 Index and Dow Jones Industrial Average also declining. This drop for Union Pacific Corp. ended a three-day winning …

CORZ Stock Forecast & Analyst Ratings - August 2026

Edward Smolyansky (LWAY) files to sell 75,000 shares after prior large sales

Edward Smolyansky has filed a Form 144 to sell up to 75,000 shares of LWAY common stock through Citigroup Global Markets Inc., with sales expected to begin on or after August 14, 2026. This filing follows several large sales of LWAY shares by Smolyansky …

Par Pacific Holdings (PARR) holder files Form 144 for NYSE stock sale

A shareholder of Par Pacific Holdings, Inc. (PARR) has filed a Form 144 to sell common stock on the NYSE, with an aggregate market value of $653,112.84. The shares, totaling 8,015, were granted as stock bonus awards in 2015 and 2025 as compensatory payments. …

Was das starke vierte Quartal 2027 von Parker-Hannifin (PH), der Gewinnprognose je Aktie und der Filtrations-Deal für die Aktionäre bedeuten

Cresud (CRESY) plans full $10.2M principal and interest payment on Series XLV notes

Cresud S.A.C.I.F. y A. (CRESY) announced it will make the fifth installment of interest and capital amortization on its Series XLV Fixed Rate Notes on August 24, 2026. The company will pay the full outstanding principal of USD 10,199,068, along with USD 204,540.21 in …

ARK reports 9.59% stake in Pacific Biosciences (PACB)

ARK Investment Management LLC and Catherine D. Wood have reported a beneficial ownership of 9.59% in Pacific Biosciences of California, Inc. (PACB), amounting to 29,781,416 shares. This disclosure, made via a SCHEDULE 13G/A filing, details their sole and shared voting and dispositive powers over …

VerifyMe Releases Q2 2026 Financial Results

VerifyMe, Inc. (VRME) reported a significant net loss of $505,000 for Q2 2026, translating to a loss of $0.04 per share, double the loss from the previous year. Revenue plunged by 58.0% year-over-year to $1.9M. Despite the weak quarterly performance, analysts maintain a largely …

Die Eiffage-Aktie hält sich über 120 Euro, H1 2026 zeigt solides Wachstum

What Parker-Hannifin (PH)'s Strong Q4, 2027 EPS Outlook and Filtration Deal Means For Shareholders

Parker-Hannifin recently reported strong Q4 2026 results with rising sales and net income, alongside positive fiscal 2027 guidance and the acquisition of Filtration Group Corporation. This move aims to reshape the company's investment narrative by expanding its filtration technologies and aftermarket footprint, potentially supporting …

Shopify (SHOP) Is Up 7.5% After Strong Q2 Earnings And AI-Led Outlook Has The Bull Case Changed?

Is MetLife (MET) Undervalued After Earnings And Its $3b Buyback?

Equifax agrees to pay $100 million over allegedly inaccurate credit scores

Equifax Information Services LLC and its parent company, Equifax Inc., have agreed to a $100 million class action settlement over allegations of inaccurate credit scores caused by a 2022 coding error. The settlement, which awaits court approval, would provide an estimated $95 to $280 …

VerifyMe reports Q2 2026 revenue $1.9M, gross margin 54%, net loss $0.5M

VerifyMe (VRME) announced its Q2 2026 financial results, reporting consolidated revenue of $1.9 million, a gross profit of $1.0 million (54% margin), and a net loss of $0.5 million. The company noted a significant year-over-year revenue decline due to an erosion of its ProActive …

ETFs Investing in Superior Group of Companies, Inc. Stocks

This article lists several ETFs that hold stocks of Superior Group of Companies, Inc. It provides a detailed table with each ETF's market value, weight of the stock, issuer, management style, focus, expense ratio, assets under management (AUM), price, change percentage, relative volume, and …

Susquehanna group reports 5.3% Medifast (MED) ownership in Schedule 13G

Susquehanna Portfolio Strategies, LLC and Susquehanna Securities, LLC have collectively reported a 5.3% beneficial ownership stake in Medifast (MED) through a Schedule 13G filing. This amounts to 587,214 shares of Medifast common stock as of June 30, 2026, including options for 542,700 shares held …

Die Edwards-Lifesciences-Aktie steigt dank starker Q2-Dynamik und hoher Bewertung

Aksh Optifibre Posts Q1 Profit Amidst CIRP, Auditors Raise Concerns